EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vivo and In Vitro Pro-Fibrotic Response of Lung-Resident Mesenchymal Stem Cells from Patients with Idiopathic Pulmonary Fibrosis

Gabriel Escarrer-Garau iD, Aina Martín-Medina, Joan Truyols-Vives iD, Cristina Gómez-Bellvert, Linda Elowsson iD, Gunilla Westergren-Thorsson iD, Maria Molina-Molina, Josep Mercader-Barceló iD, Ernest Sala-Llinàs

Cells · 2024

DOI: 10.3390/cells13020160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Gabriel Escarrer-Garau und 8 weiteren Autor:innen. Beteiligte Einrichtung: MolONE Research Group, University of the Balearic Islands (UIB), 07122 Palma, Spain. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Swedish Heart Lung foundation, Swedish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung-resident mesenchymal stem cells (LR-MSC) are thought to participate in idiopathic pulmonary fibrosis (IPF) by differentiating into myofibroblasts. On the other hand, LR-MSC in IPF patients present senescence-related features. It is unclear how they respond to a profibrotic environment. Here, we investigated the profibrotic response of LR-MSC isolated from IPF and control (CON) patients. LR-MSC were inoculated in mice 48 h after bleomycin (BLM) instillation to analyze their contribution to lung damage. In vitro, LR-MSC were exposed to TGFβ. Mice inoculated with IPF LR-MSC exhibited worse maintenance of their body weight. The instillation of either IPF or CON LR-MSC sustained BLM-induced histological lung damage, bronchoalveolar lavage fluid cell count, and the expression of the myofibroblast marker, extracellular matrix (ECM) proteins, and proinflammatory cytokines in the lungs. In vitro, IPF LR-MSC displayed higher basal protein levels of aSMA and fibronectin than CON LR-MSC. However, the TGFβ response in the expression of TGFβ, aSMA, and ECM genes was attenuated in IPF LR-MSC. In conclusion, IPF LR-MSC have acquired myofibroblastic features, but their capacity to further respond to profibrotic stimuli seems to be attenuated. In an advanced stage of the disease, LR-MSC may participate in disease progression owing to their limited ability to repair epithelial damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Pulmonary FibrosisHumansAnimalsMiceBronchoalveolar Lavage FluidBleomycinExtracellular Matrix ProteinsLungTransforming Growth Factor beta

Stichwörter der Autor:innen

bleomycinextracellular matrix proteinsidiopathic pulmonary fibrosisinflammationlung-resident mesenchymal stem cellmyofibroblasttransforming growth factor β

Substanzen

BleomycinExtracellular Matrix ProteinsTransforming Growth Factor beta

Autor:innen und Institutionen

  • MolONE Research Group, University of the Balearic Islands (UIB), 07122 Palma, Spain.
  • iRESPIRE Research Group, Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain.
  • Pathological Anatomy Service, Son Espases University Hospital, 07120 Palma, Spain.
  • Lung Biology, Department of Experimental Medical Science, Lund University, 08908 Lund, Sweden.
  • ILD Unit, Respiratory Department, University Hospital of Bellvitge-Bellvitge Biomedical Research Institute (IDIBELL), 08908 Hospitalet de Llobregat, Barcelona, Spain.
  • Centre of Biomedical Research Network in Respiratory Diseases (CIBERES), 28029 Madrid, Spain.

ORCID-Profile: Gabriel Escarrer-Garau, Joan Truyols-Vives, Linda Elowsson, Gunilla Westergren-Thorsson, Josep Mercader-Barceló

Förderung

  • Instituto de Salud Carlos III
  • Swedish Heart Lung foundation
  • Swedish Research Council
  • Swedish Foundation for Strategic research
  • Lund University Medical Faculty; the ALF project
  • Åke and Inger Bergkvist
  • Royal Physiographic Society of Lund

Zitieren

APA

Escarrer-Garau, G., Martín-Medina, A., Truyols-Vives, J., Gómez-Bellvert, C., Elowsson, L., Westergren-Thorsson, G., Molina-Molina, M., Mercader-Barceló, J., & Sala-Llinàs, E. (2024). In Vivo and In Vitro Pro-Fibrotic Response of Lung-Resident Mesenchymal Stem Cells from Patients with Idiopathic Pulmonary Fibrosis. Cells. https://doi.org/10.3390/cells13020160

Vancouver

Escarrer-Garau G, Martín-Medina A, Truyols-Vives J, Gómez-Bellvert C, Elowsson L, Westergren-Thorsson G, et al. In Vivo and In Vitro Pro-Fibrotic Response of Lung-Resident Mesenchymal Stem Cells from Patients with Idiopathic Pulmonary Fibrosis. Cells. 2024. doi:10.3390/cells13020160

BibTeX
@article{EscarrerGarau2024,
  author = {Escarrer-Garau, Gabriel and Martín-Medina, Aina and Truyols-Vives, Joan and Gómez-Bellvert, Cristina and Elowsson, Linda and Westergren-Thorsson, Gunilla and Molina-Molina, Maria and Mercader-Barceló, Josep and Sala-Llinàs, Ernest},
  title = {In Vivo and In Vitro Pro-Fibrotic Response of Lung-Resident Mesenchymal Stem Cells from Patients with Idiopathic Pulmonary Fibrosis},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13020160}
}
Kostenlos starten →